TP53 and colorectal cancer: This newest platform builds on lessons learned from those systems—particularly in prompt engineering, interface usability, and workflow transparency—and applies them to the TP53 pathway, one of the most clinically actionable and frequently altered axes in colorectal cancer, including EOCRC.